58 related articles for article (PubMed ID: 447202)
1. Anomeric specificity in the response of gut glucagon-like immunoreactive materials to glucose.
Matsuyama T; Tanaka R; Shima K; Tarui S
Horm Metab Res; 1979 Mar; 11(3):214-6. PubMed ID: 447202
[TBL] [Abstract][Full Text] [Related]
2. Effect of intraluminal bile or bile acids on release of gut glucagon-like immunoreactive materials in the dog.
Namba M; Matsuyama T; Nonaka K; Tarui S
Horm Metab Res; 1983; 15(2):82-4. PubMed ID: 6826142
[TBL] [Abstract][Full Text] [Related]
3. Effect of insulin on the response of gut glucagon-like immunoreactivity (GLI) to oral glucose and food ingestion in the goose.
Karmann H; Mialhe P
Horm Metab Res; 1987 Feb; 19(2):47-52. PubMed ID: 3549502
[TBL] [Abstract][Full Text] [Related]
4. Regional release of glucagon-like immunoreactivity from the intestine of the cat.
Frame CM
Horm Metab Res; 1977 Mar; 9(2):117-20. PubMed ID: 863376
[TBL] [Abstract][Full Text] [Related]
5. Purification of canine gut glucagon-like immunoreactivity (GLI) and its insulin releasing activity.
Ohneda A; Horigome K; Kai Y; Itabashi H; Ishii S; Yamagata S
Horm Metab Res; 1976 May; 8(3):170-4. PubMed ID: 939462
[TBL] [Abstract][Full Text] [Related]
6. The effect of calcium and other salts upon the release of glucagon-like immunoreactivity from the gut.
Böttger I; Faloona GR; Unger RH
J Clin Invest; 1972 Apr; 51(4):831-6. PubMed ID: 5014613
[TBL] [Abstract][Full Text] [Related]
7. Decrease in blood glucose and release of gut glucagon-like immunoreactive materials by bombesin infusion in the dog.
Matsuyama T; Namba M; Nonaka K; Tarui S; Tanaka R; Shima K
Endocrinol Jpn; 1980 Dec; 27 Suppl 1():115-9. PubMed ID: 7014201
[TBL] [Abstract][Full Text] [Related]
8. The use of perfused rat intestine to characterise the glucagon-like immunoreactivity released into serosal secretions following stimulation by glucose.
O'Connor FA; Conlon JM; Buchanan KD; Murphy RF
Horm Metab Res; 1979 Jan; 11(1):19-23. PubMed ID: 428905
[TBL] [Abstract][Full Text] [Related]
9. Glucose, insulin, pancreatic glucagon and glucagon-like immunoreactive materials in the plasma of normal and diabetic children. Effect of the initial insulin treatment.
Matsuyama T; Hoffman WH; Dunbar JC; Foà NL; Foà PP
Horm Metab Res; 1975 Nov; 7(6):452-6. PubMed ID: 1213649
[TBL] [Abstract][Full Text] [Related]
10. The contribution of the distal gastrointestinal tract to glucagon-like immunoreactivity secretion in the rat.
Frame CM
Proc Soc Exp Biol Med; 1976 Sep; 152(4):667-70. PubMed ID: 967899
[TBL] [Abstract][Full Text] [Related]
11. Response of extrapancreatic immunoreactive glucagon to intraluminal nutrients in pancreatectomized dogs.
Ohneda A; Kobayashi T; Nihei J
Horm Metab Res; 1984 Jul; 16(7):344-8. PubMed ID: 6386643
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of pancreatic exocrine secretion and augmentation of the release of gut glucagon-like immunoreactive materials by intraileal administration of bile in the dog.
Namba M; Matsuyama T; Horie H; Nonaka K; Tarui S
Regul Pept; 1983 Feb; 5(3):257-62. PubMed ID: 6844666
[TBL] [Abstract][Full Text] [Related]
13. Attenuated anomeric difference of glucose-induced insulin release in the perfused pancreas of diazoxide-treated rats.
Leclercq-Meyer V; Marchand J; Malaisse WJ
Horm Metab Res; 1991 Jun; 23(6):257-61. PubMed ID: 1916634
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of glucagon secretion.
Young A
Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
[TBL] [Abstract][Full Text] [Related]
15. Effects of amino-acids on pancreatic hormones and gut glucagon-like immunoreactivity in the goose.
Khemiss F; Sitbon G
Horm Metab Res; 1982 Mar; 14(3):122-7. PubMed ID: 6896041
[TBL] [Abstract][Full Text] [Related]
16. Chromatographic pattern of gut glucagon-like immunoreactivity (GLI) in plasma before and during glucose absorption.
Valverde I; Ghiglione M; Matesanz R; Casado S
Horm Metab Res; 1979 May; 11(5):343-6. PubMed ID: 478429
[TBL] [Abstract][Full Text] [Related]
17. [Effect of insulin and glucagon on the anomeric composition of D-glucose in blood (author's transl)].
Madreiter H; Jarosch E; Richter H
Padiatr Padol; 1975; 10(3):230-6. PubMed ID: 1196660
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic glucagon-like immunoreactivity in a pancreatectomized patient.
Botha JL; Vinik AI; Child PT; Paul M; Jackson WP
Horm Metab Res; 1977 May; 9(3):199-205. PubMed ID: 885471
[TBL] [Abstract][Full Text] [Related]
19. Peculiar glucagon processing in the intestine is the genesis of the paradoxical rise of serum pancreatic glucagon in patients after total pancreatectomy.
Tanjoh K; Tomita R; Fukuzawa M; Hayashi N
Hepatogastroenterology; 2003; 50(50):535-40. PubMed ID: 12749267
[TBL] [Abstract][Full Text] [Related]
20. The peculiar processing of glucagon and glucagon-related peptides in patients after pancreatectomy.
Tanjoh K; Tomita R; Hayashi N
Hepatogastroenterology; 2002; 49(45):825-32. PubMed ID: 12064000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
